Despite all the great news pps stuck at sub sub penny. Seems to be floating a long time at it's lows. I got in at it's high of .0037 without knowing of it's CE label. Speculating that with approval of Actipatch this was sure to jump to over a penny. Great products that are sure to help millions with chronic pain deserves higher evaluation even with the high number of o/s. I guess it's show me the revenue driven. Maybe pps recovery in October after final FDA approval. We shall see. It will be cool if then partnerships announced coincide with revenue hikes and approval. Then watch this baby go. In mean time picked up another million to help cost average stash while we continue to wait.